Clown-care reduces pain in children with cerebral palsy undergoing recurrent botulinum toxin injections- A quasi-randomized controlled crossover study

PLoS One. 2017 Apr 17;12(4):e0175028. doi: 10.1371/journal.pone.0175028. eCollection 2017.

Abstract

Objective: We investigated the impact of clown-care on pain in 45 children with cerebral palsy who underwent recurrent Botulinum-toxin injections (age 7.04± 4.68 years). Participants were randomized to receive either clown (n = 20) or standard (n = 25) -care.

Methods: Pain Visual-Analogue-Scale (range 1-5) was reported before and after procedures. Pain assessment was lower for children undergoing Botulinum-toxin injections with clown-care (2.89± 1.36) compared to standard-care (3.85± 1.39; p = 0.036) even though pain anticipated prior to procedures was similar (~3).

Findings: Children who underwent the first procedure with clown-care reported lower pain even after they crossed-over to the following procedure which was standard (p = 0.048). Carryover effect was more prominent in injection-naïve children (p = 0.019) and during multiple procedures (p = 0.009). Prior pain experience correlated with pain in subsequent procedures only when first experience was standard-care (p = 0.001).

Conclusions: Clown-care alleviated pain sensation during Botulinum-toxin injections and initial clown-care experience reduced pain during subsequent injections even though clowns were not present.

Trial registration: clinicaltrials.gov ID # NCT01377883.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Botulinum Toxins / administration & dosage*
  • Cerebral Palsy / drug therapy
  • Cerebral Palsy / physiopathology
  • Cerebral Palsy / therapy*
  • Child
  • Child, Preschool
  • Cross-Over Studies
  • Female
  • Humans
  • Infant
  • Injections, Intramuscular
  • Israel
  • Laughter Therapy / methods*
  • Male
  • Muscle Hypertonia / drug therapy
  • Muscle Hypertonia / physiopathology
  • Neuromuscular Agents / administration & dosage
  • Pain / physiopathology
  • Pain / prevention & control*
  • Pain Management / methods*
  • Pain Measurement
  • Treatment Outcome

Substances

  • Neuromuscular Agents
  • Botulinum Toxins

Associated data

  • ClinicalTrials.gov/NCT01377883